Resources
Below you will find our available resources, including links to our publications and other useful sites.
Online Resources
Yale neither endorses nor verifies the accuracy of any information contained in the following web sites.
Patient Associations:
- The Myositis Association (TMA)
- MDA’s web page on Inclusion-Body Myositis
- Myositis Support and Understanding
Research Institutions:
- National Institute of Neurological Disorders and Stroke’s (NINDS) Inclusion Body Myositis Information Page
- The John Hopkins Myositis Center
- Cleveland Clinic
- Program in Clinical & Translational Neuromuscular Research (CTNR)
- National Center for Advancing Translational Sciences (NCATS) Genetic and Rare Diseases (GARD) Information Center
- National Center for Biotechnology Information
Personal Sites & IBM Patient Blogs:
Other Sites:
- “Patients Like Me” web site
- American Autoimmune Related Diseases Association, Inc. (AARDA)
- Living With Myositis
- Orphanet portal for rare diseases and orphan drugs
- Patient.co.uk
- Wikipedia
- Myositis Support & Understanding
- Inclusion Body Myositis Support and Understanding Facebook Group
Online Publications:
Publications
- Mutual reinforcement of lymphotoxin-driven myositis and impaired autophagy in murine muscle.Bremer J, Nagel J, Zschüntzsch J, Zajt KK, Palaz T, Blank T, Ikis A, Fischer LA, Sensmeyer ASM, Wiechers L, Reichelt JJ, Hofmann KP, Wolf MJ, Leuchtenberger C, Tripathi P, Einer C, Zischka H, Rothermel U, Eck AL, Reimann RR, Kana V, Rushing E, Aguzzi A, Prinz M, Liebetanz D, Odoardi F, Kuo CC, Weis J, Kraft F, Schmidt J, Heikenwälder M. Brain. 2025 Dec 4. PMID: 40853947.
- [A case of inclusion body myositis with childhood onset].Qiu LZ, Wu D, Fan ZD, Guo YH, Ma L, Yu HG. Zhonghua Er Ke Za Zhi. 2025 Dec 2. PMID: 41233136.
- Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patients.Vicino A, Lauletta A, Bonanno S, Barbaccia A, Valentino ML, Risi B, Torchia E, Cheli M, Tonin P, Urbano G, Saccani E, Faedo E, Ruggieri A, Iannibelli E, Croce MG, Zoppi D, Costantini EM, Rigamonti A, Colacicco G, Grandis M, Coccia M, Barp A, Stephan AM, Carda S, Théaudin M, Ravaglia S, Ruggiero L, Mongini T, Verriello L, Vattemi G, Bortolani S, Sansone VA, Filosto M, Previtali SC, Liguori R, Rodolico C, Garibaldi M, Maggi L. J Neurol. 2025 Nov 19; 2025 Nov 19. PMID: 41258934.
- Emerging Treatment Options for Inclusion Body Myositis.Lilleker JB, Brady S. Rheum Dis Clin North Am. 2025 Nov; 2025 Sep 9. PMID: 41161903.
- Updates on Diagnostic Criteria of Inclusion Body Myositis.Naddaf E, Roy B. Rheum Dis Clin North Am. 2025 Nov; 2025 Sep 19. PMID: 41161902.
- Inclusion Body Myositis.Naddaf E. Continuum (Minneap Minn). 2025 Oct; 2025 Oct 2. PMID: 41037166.
- Myopathology and Immune Profile of Granulomatous Myositis in Sarcoid Myopathy.Ruffer N, Pinal-Fernandez I, Kleefeld F, Holzer MT, Goebel HH, Schänzer A, Casal-Dominguez M, Kötter I, Görl N, Masuhr F, Alten R, Braasch E, Grüger A, Müller J, Lempert T, Krause A, Huber TB, Liewluck T, Mammen AL, Stenzel W, Preusse C, Schneider U, Krusche M. Neuropathol Appl Neurobiol. 2025 Oct. PMID: 40928208.
- Inclusion body myositis - what are new lines of pathogenesis and therapy?Krause K, Ruck T, Kleefeld F. Curr Opin Neurol. 2025 Oct 1; 2025 Jun 5. PMID: 40471678.
- Mitochondrial damage is associated with an early immune response in inclusion body myositis.Kleefeld F, Cross E, Lagos D, Walli S, Schoser B, Hentschel A, Ruck T, Nelke C, Hahn K, Hathazi D, Mammen AL, Casal-Dominguez M, Gut M, Gut IG, Heath S, Schänzer A, Goebel HH, Pinal-Fernandez I, Roos A, Preuße C, Stenzel W, Horvath R. Brain. 2025 Sep 3. PMID: 40193586.
- A Scoping Review of Respiratory Dysfunction in Inclusion Body Myositis.Ambrocio KR, Ragusa BR, Aggarwal R, Lacomis D, Kouame G, Garand KL. Int J Rheum Dis. 2025 Sep. PMID: 40913301.
- LAG3 Is Expressed on Muscle-Infiltrating Cytotoxic T Cells, but Scarce on Circulating T Cells, in Patients With Inclusion Body Myositis.Mukasa R, Ogata S, Kiyosawa N, Shibutani T, Kashimoto Y, Watanabe K, Kusama M, Takizawa H, Sato N, Nishino I, Mori-Yoshimura M. Muscle Nerve. 2025 Sep; 2025 Jun 9. PMID: 40485502.
- Small Fiber Morphology and Function in Inclusion Body Myositis-A Multimodal Assessment Including Confocal Corneal Microscopy.Sturm D, Güttsches AK, Vorgerd M, Schwenkreis P, Westermann A, Greiner T, Vollert J, Eitner L, Maier C, Forsting J, Enax-Krumova E. Eur J Neurol. 2025 Aug. PMID: 40729458.
- Mitochondria-centred metabolomic map of inclusion body myositis: sex-specific alterations in central carbon metabolism.Naddaf E, Shammas I, Dasari S, Petterson XT, Springer W, Trushina E, Lanza IR. Ann Rheum Dis. 2025 Aug; 2025 May 30. PMID: 40450407.
- Interferon-γ causes myogenic cell dysfunction and senescence in immune myopathies.Hou C, Periou B, Gervais M, Martin L, Berthier J, Baba-Amer Y, Souvannanorath S, Lechapt-Zalcman E, Malfatti E, Gherardi RK, Relaix F, Bencze M, Authier FJ. Brain. 2025 Aug 1. PMID: 40296760.
- Strapped for Strength: A Comparison Study of Dynamometry Techniques to Evaluate Knee Extensor Strength in Inclusion Body Myositis.Schütze K, Cooper I, Galna B, Beer K, Fairchild TJ, Schopp M, Brusch A, Needham M. Muscle Nerve. 2025 Jul; 2025 Apr 3. PMID: 40177792.
- A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis.Naddaf E, Skolka MP, Prokop L, Dimachkie MM, Hogrel JY, Benveniste O, Wang Z, Mandrekar J, West CP, Murad MH. Rheumatology (Oxford). 2025 Jul 1. PMID: 40085004.
- The clinical features, muscle pathology, and role of autophagy in anti-Ku-positive patients.Qiao L, Lin Y, Liu M, Liu J, Li K, Chen J, Shi Q. Front Immunol. 2025; 2025 Jun 17. PMID: 40599787.
- Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body Myositis.de Vries GM, Asselbergh B, Monticelli A, De Jonghe P, Maudsley S, Van Den Bergh PYK, Bigot A, De Bleecker JL, Ermanoska B, De Ridder W, Baets J. J Cachexia Sarcopenia Muscle. 2025 Jun. PMID: 40485189.
- Characterizing local antibody responses in the muscle of inclusion body myositis patients.Jayaraman S, Wilson A, Zheng XA, Montagne JM, Pinal-Fernandez I, Mammen AL, Lloyd TE, Larman HB. J Autoimmun. 2025 Jun; 2025 May 26. PMID: 40424896.
- Alpha-Synuclein as a Potential Biomarker for Inclusion Body Myositis in Blood and Muscle.Mayer T, Scholle L, Foerster L, Schneider I, Stoltenburg-Didinger G, Delank KS, Kendzierski T, Koelsch A, Kleeberg K, Kraya T, Barba L, Naegel S, Schänzer A, Otto M, Mensch A. Neuropathol Appl Neurobiol. 2025 Jun. PMID: 40384347.
- Increased Risk of Myocardial Infarction in Inclusion Body Myositis: A Non-Concurrent Cohort Study.Beecher G, Muhammad S, Shammas I, Chamberlain AM, Larson K, Mandrekar J, Harmsen WS, Naddaf E. Eur J Neurol. 2025 May. PMID: 40297918.
- Loss of TDP-43 Splicing Repression Occurs in Myonuclei of Inclusion Body Myositis Patients.Ikenaga C, Wilson AB, Irwin KE, Peethambaran Mallika A, Kilgore C, Sinha IR, Michelle EH, Ling JP, Wong PC, Lloyd TE. Ann Neurol. 2025 Apr; 2025 Jan 6. PMID: 39757935.
- Intramyocardial fatty infiltration lesion in sporadic inclusion body myositis: a case report.Redzepi B, Théaudin M, Bengueddache S, Petropoulou-Natsou S, Masi A, Rodrigues D, Tzimas G, Schwitter J, Antiochos P. Int J Cardiovasc Imaging. 2025 Apr; 2024 Oct 28. PMID: 39466494.
- Inclusion body myositis and immunosenescence: current evidence and future perspectives.Allameen NA, Salam S, Reddy V, Machado PM. Rheumatology (Oxford). 2025 Mar 1. PMID: 39504446.
- Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.Astouati Q, Machet T, Houssais C, Noury JB, Allenbach Y, Gallay L, Quere B, Assan F, Benveniste O, Broner J, Duffau P, Espitia A, Grasland A, Hayem G, Le Guern V, Martis N, Mariampillai K, Nocturne G, Mariette X, Meyer A, Mulleman D, Devauchelle-Pensec V, Collet A, Launay D, Hachulla E, Cornec D, Guellec D, Sanges S. Rheumatology (Oxford). 2025 Mar 1. PMID: 38430004.
- Human induced pluripotent stem cell-derived myotubes to model inclusion body myositis.Cantó-Santos J, Valls-Roca L, Tobías E, García-García FJ, Guitart-Mampel M, Andújar-Sánchez F, Vilaseca-Capel A, Esteve-Codina A, Martín-Mur B, Padrosa J, Peruga E, Madrigal I, Segalés P, García-Ruiz C, Fernández-Checa JC, Moreno-Lozano PJ, O'Callaghan AS, Sevilla A, Milisenda JC, Garrabou G. Acta Neuropathol Commun. 2025 Feb 21; 2025 Feb 21. PMID: 39985015.
- Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomol.Salam S, Morrow JM, McDermott MP, Zafeiropoulos N, Thornton JS, Shah S, Wastling S, Yousry TY, Barohn RJ, Hanna MG, Dimachkie MM, Machado PM. Clin Exp Rheumatol. 2025 Feb; 2025 Feb 26. PMID: 40018748.
- Challenges in international investigator-led rare disease clinical trials and the case for optimism in inclusion body myositis.Needham M, Badrising UA, Beer K, Heim AJ, Doverty A, Panicker A, Benveniste O, Dimachkie MM. Clin Exp Rheumatol. 2025 Feb; 2025 Feb 26. PMID: 40018747.
- Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale.Badrising UA, Henderson R, Reddel S, Corbett A, Liang C, Reardon K, Ghaoui R, Bulsara M, Brady S, Brusch A, Chan D, Coudert JD, Fairchild T, Jain G, Kiernan MC, Leonard D, Lloyd T, Schmidt J, McDermott MP, Sanders L, Lowe C, van der Kooi AJ, Weihl C, Mohassel P, Simpson M, Carroll A, Cooper I, Beer K, Hiscock K, Walters S, Panicker A, Doverty A, Heim A, van Heur-Neuman M, Benveniste O, Dimachkie MM, Needham M. Clin Exp Rheumatol. 2025 Feb; 2025 Feb 26. PMID: 40018746.
- Imaging evaluation of the upper limbs in inclusion body myositis: an unmet need.Salam S, Morrow JM, Shah S, Hanna MG, Dimachkie MM, Machado PM. Clin Exp Rheumatol. 2025 Feb; 2025 Feb 14. PMID: 39977010.
- Determining patient and carer priorities in inclusion body myositis: a patient-led research study.Austin KL, Hawkins B, Beer KA, Doverty AB, Needham M. Clin Exp Rheumatol. 2025 Feb; 2025 Feb 13. PMID: 39946183.
- NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis.Naddaf E, Nguyen TKO, Watzlawik JO, Gao H, Hou X, Fiesel FC, Mandrekar J, Kokesh E, Harmsen WS, Lanza IR, Springer W, Trushina E. J Cachexia Sarcopenia Muscle. 2025 Feb. PMID: 39723571.
- Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review.Santos EJF, Farisogullari B, Yapp N, Townsley H, Sousa P, Machado PM. RMD Open. 2025 Jan 22; 2025 Jan 22. PMID: 39843353.
- Measurement properties of the Inclusion Body Myositis Functional Rating Scale.Salam S, Symonds T, Doll H, Rousell S, Randall J, Lloyd-Price L, Hudgens S, Guldberg C, Herbelin L, Barohn RJ, Hanna MG, Dimachkie MM, Machado PM. J Neurol Neurosurg Psychiatry. 2025 Jan 16; 2025 Jan 16. PMID: 38960586.
- Multi-omics analysis in inclusion body myositis identifies mir-16 responsible for HLA overexpression.Wijnbergen D, Johari M, Ozisik O, 't Hoen PAC, Ehrhart F, Baudot A, Evelo CT, Udd B, Roos M, Mina E. Orphanet J Rare Dis. 2025 Jan 15; 2025 Jan 15. PMID: 39815348.
- Association of HLA-DR, HLA-DQ, and HLA-B alleles with inclusion body myositis risk: A systematic review, a meta-analysis, a meta-regression and a trial sequential analysis.Dhaouadi T, Riahi A, Ben Abdallah T, Gorgi Y, Sfar I. Int J Immunopathol Pharmacol. 2025 Jan-Dec. PMID: 39959993.
- The relationship between patient-reported and clinician-assessed outcome measures in Inclusion body myositis - insights from a retrospective cohort study.Schopp M, Beer K, Cooper I, Hird K, Doverty A, Panicker A, Schütze K, Brusch A, Needham M. Neuromuscul Disord. 2025 Jan; 2024 Dec 20. PMID: 39799668.
- Inclusion body myositis: an update.Anderson NC, Lloyd TE. Curr Opin Rheumatol. 2025 Jan 1; 2024 Oct 21. PMID: 39469805.
- Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.Notarnicola A, Hellstrom C, Horuluoglu B, Pin E, Preger C, Bonomi F, De Paepe B, De Bleecker JL, Van der Kooi AJ, De Visser M, Sacconi S, Machado P, Badrising UA, Rietveld A, Pruijn G, Rothwell S, Lilleker JB, Chinoy H, Benveniste O, Svenungsson E, Idborg H, Jakobsson PJ, Nilsson P, Lundberg IE. J Autoimmun. 2024 Dec; 2024 Nov 18. PMID: 39561568.
- Volumetric muscle composition analysis in sporadic inclusion body myositis using fat-referenced magnetic resonance imaging: Disease pattern, repeatability, and natural progression.Heerfordt J, Karlsson M, Kusama M, Ogata S, Mukasa R, Kiyosawa N, Sato N, Widholm P, Dahlqvist Leinhard O, Ahlgren A, Mori-Yoshimura M. Muscle Nerve. 2024 Dec; 2024 Sep 24. PMID: 39318110.
- Inclusion body myositis triggerred with long-term imatinib use.Deniz R, Güzelbey T, Narinoğlu S, Şirin Kalem G, Ekmen ŞA, Gündoğdu Ünverengil G, Karaali Z. J Oncol Pharm Pract. 2024 Dec; 2023 Apr 10. PMID: 37038366.
- Features of Swallowing Function in Sporadic Inclusion Body Myositis: Preliminary Evidence Using Well-Tested Assessment Frameworks.Ambrocio KR, Aggarwal R, Lacomis D, Zhang X, Garand KLF. Am J Speech Lang Pathol. 2024 Nov 4; 2024 Oct 11. PMID: 39392897.
- Current biomarkers in inclusion body myositis.Daniel E, Smith IC, Sampaio ML, Melkus G, Hamilton LE, Bourque PR, Warman-Chardon J. J Neuromuscul Dis. 2024 Nov; 2024 Oct 29. PMID: 39967427.
- Inclusion Body Myositis: A case report on navigating diagnostic challenges.Al Sharji M, Al Busaidi S, Al Jahdhami S, Jawa Z, Farhan H, Al Alawi AM. Sultan Qaboos Univ Med J. 2024 Nov; 2024 Nov 27. PMID: 39634801.
- Inclusion Body Myositis: A Late Diagnosis Case Report.Hernández-Rivero DA, Bazán-Rodríguez L, Cruz-Domínguez MDP, Medina G, Peralta Amaro AL, Vera-Lastra O. Reumatol Clin (Engl Ed). 2024 Nov; 2024 Oct 28. PMID: 39472181.
- Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy.Brady S, Poulton J, Muller S. Autoimmun Rev. 2024 Nov; 2024 Sep 19. PMID: 39306221.
- Impact of sex, age at onset, and anti-cN1A antibodies on sporadic inclusion body myositis.Yamashita S, Tawara N, Sugie K, Suzuki N, Nishino I, Aoki M. J Neurol Sci. 2024 Sep 15; 2024 Aug 6. PMID: 39126732.
- Sarcoid myopathy: an insidious diagnosis that can mimic inclusion body myositis.Mathias K, Konig MF, Lloyd T, Albayda J. Rheumatology (Oxford). 2024 Sep 1. PMID: 38466916.
- Sporadic inclusion body myositis-derived myotube culture revealed muscle cell-autonomous expression profiles.Suzuki N, Kanzaki M, Koide M, Izumi R, Fujita R, Takahashi T, Ogawa K, Yabe Y, Tsuchiya M, Suzuki M, Harada R, Ohno A, Ono H, Nakamura N, Ikeda K, Warita H, Osana S, Oikawa Y, Toyohara T, Abe T, Rui M, Ebihara S, Nagatomi R, Hagiwara Y, Aoki M. PLoS One. 2024; 2024 Aug 1. PMID: 39088432.
- Treatment resistance in inclusion body myositis: the role of mast cells.Acosta I, Hofer M, Hilton-Jones D, Squier W, Brady S. Neuromuscul Disord. 2024 Aug; 2024 May 3. PMID: 38865916.
- Cell type mapping of inflammatory muscle diseases highlights selective myofiber vulnerability in inclusion body myositis.Wischnewski S, Thäwel T, Ikenaga C, Kocharyan A, Lerma-Martin C, Zulji A, Rausch HW, Brenner D, Thomas L, Kutza M, Wick B, Trobisch T, Preusse C, Haeussler M, Leipe J, Ludolph A, Rosenbohm A, Hoke A, Platten M, Weishaupt JH, Sommer CJ, Stenzel W, Lloyd TE, Schirmer L. Nat Aging. 2024 Jul; 2024 Jun 4. PMID: 38834884.
- Bilateral Facial Palsy: A Rare Presenting Symptom for Inclusion Body Myositis.Meer E, Ahmad M, Grob S, Winn BJ. Ophthalmic Plast Reconstr Surg. 2024 Jul-Aug 01; 2024 Feb 2. PMID: 38319192.
- Association between ZASP/LDB3 Pro26Ser and Inclusion Body Myopathy.Piga D, Zanotti S, Ripolone M, Napoli L, Ciscato P, Gibertini S, Maggi L, Fortunato F, Rigamonti A, Ronchi D, Comi GP, Corti S, Sciacco M. Int J Mol Sci. 2024 Jun 14; 2024 Jun 14. PMID: 38928252.
- Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy.Reyngoudt H, Baudin PY, Caldas de Almeida Araújo E, Bachasson D, Boisserie JM, Mariampillai K, Annoussamy M, Allenbach Y, Hogrel JY, Carlier PG, Marty B, Benveniste O. J Cachexia Sarcopenia Muscle. 2024 Jun; 2024 Apr 13. PMID: 38613252.
- Effects of sporadic inclusion body myositis on skeletal muscle fibre type specific morphology and markers of regeneration and inflammation.Jensen KY, Nielsen JL, Aagaard P, Jacobsen M, Jørgensen AN, Bech RD, Frandsen U, Diederichsen LP, Schrøder HD. Rheumatol Int. 2024 Jun; 2024 Apr 6. PMID: 38581449.
- Cross-sectional study of patients with VCP multisystem proteinopathy 1 using dual-energy x-ray absorptiometry.Columbres RCA, Luu V, Nguyen M, Kimonis V. Muscle Nerve. 2024 Jun; 2024 Mar 29. PMID: 38551101.
- VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models.Phan JM, Creekmore BC, Nguyen AT, Bershadskaya DD, Darwich NF, Mann CN, Lee EB. J Clin Invest. 2024 May 23; 2024 May 23. PMID: 38787785.
- Inclusion body myositis, viral infections, and TDP-43: a narrative review.Văcăraş V, Vulturar R, Chiş A, Damian L. Clin Exp Med. 2024 May 2; 2024 May 2. PMID: 38693436.
- [Sporadic Inclusion Body Myositis].Aoki M, Izumi R, Suzuki N. Brain Nerve. 2024 May. PMID: 38741510.
- Evaluating disease status in idiopathic inflammatory myopathies with quantitative muscle ultrasound.Tan JY, Tan CY, Yahya MA, Shahrizaila N, Goh KJ. Muscle Nerve. 2024 May; 2024 Mar 15. PMID: 38488306.
- Inclusion body myositis.Warman-Chardon J, Breiner A, Bourque PR. CMAJ. 2024 Apr 14; 2024 Apr 14. PMID: 38621777.
- Quantum simulation of Pauli channels and dynamical maps: Algorithm and implementation.Basile T, Pineda C. PLoS One. 2024; 2024 Apr 10. PMID: 38598439.
- 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16-18 June 2023, Hoofddorp, The Netherlands.Lilleker JB, Naddaf E, Saris CGJ, Schmidt J, de Visser M, Weihl CC. Neuromuscul Disord. 2024 Apr; 2024 Mar 7. PMID: 38522330.
- Does inspiratory muscle training improve lung function and quality of life in people with inclusion body myositis? A pilot study.Williams E, Cooper I, Beer K, Hird K, Cavalheri V, Watson K, Needham M. Neuromuscul Disord. 2024 Apr; 2024 Feb 22. PMID: 38489862.
- HIV-associated nemaline myopathy manifesting as bent spine syndrome.Nasir AZ, Jameson A. BMJ Case Rep. 2024 Mar 12; 2024 Mar 12. PMID: 38471704.
- Bone scan findings of Paget's disease of bone in patients with VCP Multisystem Proteinopathy 1.Columbres RCA, Din S, Gibbs L, Kimonis V. Sci Rep. 2024 Mar 11; 2024 Mar 11. PMID: 38467645.
- Relationship Between Hand Function and Handheld Ultrasound Imaging in Inclusion Body Myositis.Black C, Cai H, Shabbir A, Wang LH. J Clin Neuromuscul Dis. 2024 Mar 1. PMID: 38441927.
- Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging.Guglielmi V, Cheli M, Tonin P, Vattemi G. Int J Mol Sci. 2024 Feb 27; 2024 Feb 27. PMID: 38473988.
- Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.Sun C, Tian X, Yang H, Yang H, Li S, Jiang W, Peng Q, Wang G, Lu X. Clin Exp Rheumatol. 2024 Feb; 2024 Mar 14. PMID: 38488095.
- Phenotypic spectrum of inclusion body myositis.Roy B, Dimachkie MM, Naddaf E. Clin Exp Rheumatol. 2024 Feb; 2024 Feb 28. PMID: 38436356.
- Imaging swallowing function and the mechanisms driving dysphagia in inclusion body myositis.Salam S, Allen J, Dimachkie MM, Hanna MG, Machado PM. Clin Exp Rheumatol. 2024 Feb; 2024 Feb 16. PMID: 38372730.
- Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence?Fontanelli L, Vadi G, Schirinzi E, Di Rauso G, Bellini G, Ricci G, Siciliano G. Clin Exp Rheumatol. 2024 Feb; 2024 Feb 19. PMID: 38372729.
- Mitochondrial transfer and implications for muscle function in idiopathic inflammatory myopathies.Gonzalez Chapa JA, Barguil Macêdo M, Naddaf E, Saketkoo LA, Lood C. Clin Exp Rheumatol. 2024 Feb; 2024 Jan 25. PMID: 38293948.
- A longitudinal study using B mode ultrasound and power Doppler as monitoring imaging tools in inclusion body myositis.Paramalingam S, Needham M, Mastaglia FL, Keen HI. Clin Exp Rheumatol. 2024 Feb; 2023 Oct 13. PMID: 37877419.
- The spectrum of idiopathic inflammatory myopathies in Western Australia: epidemiological characteristics and mortality over time.Nossent J, Keen H, Preen DB, Inderjeeth CA. Rheumatol Int. 2024 Feb; 2023 Oct 11. PMID: 37819456.
- msp1, msp2, and glurp genotyping to differentiate Plasmodium falciparum recrudescence from reinfections during prevention of reestablishment phase, Sri Lanka, 2014-2019.Gunasekera KT, Premaratne RG, Handunnetti SM, Weerasena J, Premawansa S, Fernando DS. Malar J. 2024 Jan 27; 2024 Jan 27. PMID: 38281044.
- Frequency of EMG abnormalities in idiopathic inflammatory myopathies under the EULAR/ACR classification criteria.Hokkoku K, Yamamoto J, Uchida Y, Kondo A, Mukai T, Hatanaka Y, Kono H, Shimizu J, Kobayashi S, Sonoo M. Medicine (Baltimore). 2024 Jan 26. PMID: 38277547.
- Quantitative muscle MRI in sporadic inclusion body myositis (sIBM): A prospective cohort study.Schlaffke L, Rehmann R, Froeling M, Güttsches AK, Vorgerd M, Enax-Krumova E, Forsting J. J Neuromuscul Dis. 2024. PMID: 39031378.
- Paraneoplastic myopathies.Mammen AL. Handb Clin Neurol. 2024. PMID: 38494286.
- Adolescent-onset multisystem proteinopathy due to a novel VCP variant.Soontrapa P, Seven NA, Liewluck T, Cui G, Mer G, Milone M. Neuromuscul Disord. 2024 Jan; 2023 Dec 10. PMID: 38159460.
- High-resolution HLA genotyping in inclusion body myositis refines 8.1 ancestral haplotype association to DRB1*03:01:01 and highlights pathogenic role of arginine-74 of DRβ1 chain.Slater N, Sooda A, McLeish E, Beer K, Brusch A, Shakya R, Bundell C, James I, Chopra A, Mastaglia FL, Needham M, Coudert JD. J Autoimmun. 2024 Jan; 2023 Dec 2. PMID: 38043487.
- Face to Face: deciphering facial involvement in inclusion body myositis.Fortanier E, Delmont E, Kouton L, Corazza G, Grapperon AM, Verschueren A, Attarian S, Salort-Campana E. J Neurol. 2024 Jan; 2023 Sep 23. PMID: 37740740.
- Myasthenia gravis with inclusion body myositis: A case report.Kakutani T, Yoshizawa M. Mod Rheumatol Case Rep. 2023 Dec 29. PMID: 37210209.
- Update on the evaluation and management of dysphagia in sporadic inclusion body myositis.Garand KLF, Malandraki GA, Dimachkie MM. Curr Opin Otolaryngol Head Neck Surg. 2023 Dec 1; 2023 Sep 1. PMID: 37678324.
- Prominent mitochondrial pathology in a case of refractory dermatomyositis: coincidence or concause?Lauletta A, De Carolis L, Teresi V, Fionda L, Leonardi L, Ceccanti M, Costanzo R, Rossini E, Tufano L, Merlonghi G, Morino S, Garibaldi M. Neurol Sci. 2023 Dec; 2023 Aug 25. PMID: 37624542.
- Pathogenic role of anti-cN1A autoantibodies in sporadic inclusion body myositis.Yamashita S, Tawara N, Zhang Z, Nakane S, Sugie K, Suzuki N, Nishino I, Aoki M. J Neurol Neurosurg Psychiatry. 2023 Dec; 2023 Jul 14. PMID: 37451693.
- Efficacy of endoscopic cricopharyngeal myotomy using a curved rigid laryngoscope in patients with sporadic inclusion body myositis: four retrospective case reviews.Shigeyama M, Nishio N, Yokoi S, Mukoyama N, Wada A, Maruo T, Noda S, Murakami A, Tsuboi T, Katsuno M, Fujimoto Y, Sone M. Nagoya J Med Sci. 2023 Nov. PMID: 38155617.
- Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis.Nelke C, Schroeter CB, Theissen L, Preusse C, Pawlitzki M, Räuber S, Dobelmann V, Cengiz D, Kleefeld F, Roos A, Schoser B, Brunn A, Neuen-Jacob E, Zschüntzsch J, Meuth SG, Stenzel W, Ruck T. Acta Neuropathol. 2023 Nov; 2023 Sep 29. PMID: 37773216.
- Exploring challenges in the management and treatment of inclusion body myositis.Skolka MP, Naddaf E. Curr Opin Rheumatol. 2023 Nov 1; 2023 Jul 25. PMID: 37503813.
- Inclusion body myositis with early onset: a population-based study.Lindgren U, Hedberg-Oldfors C, Pullerits R, Lindberg C, Oldfors A. J Neurol. 2023 Nov; 2023 Jul 27. PMID: 37498322.
- Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany.Senn KC, Thiele S, Kummer K, Walter MC, Nagels KH. Orphanet J Rare Dis. 2023 Oct 25; 2023 Oct 25. PMID: 37880781.
- Single cell RNA sequencing sheds light on infiltrating T cells in idiopathic inflammatory myopathies.Yazdani M, Mach L, Noseda M. EMBO Mol Med. 2023 Oct 11; 2023 Sep 28. PMID: 37768011.
- Inclusion body myositis-health-related quality of life and care situation during phases of the "patience journey" in Germany: results from a qualitative study.Senn KC, Thiele S, Gumbert L, Krause S, Walter MC, Nagels KH. Health Qual Life Outcomes. 2023 Oct 10; 2023 Oct 10. PMID: 37817114.
- Diagnosing and managing dysphagia in inclusion body myositis: a systematic review.Ambrocio KR, Garand KLF, Roy B, Bhutada AM, Malandraki GA. Rheumatology (Oxford). 2023 Oct 3. PMID: 37115631.
- Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.Machado PM, McDermott MP, Blaettler T, Sundgreen C, Amato AA, Ciafaloni E, Freimer M, Gibson SB, Jones SM, Levine TD, Lloyd TE, Mozaffar T, Shaibani AI, Wicklund M, Rosholm A, Carstensen TD, Bonefeld K, Jørgensen AN, Phonekeo K, Heim AJ, Herbelin L, Barohn RJ, Hanna MG, Dimachkie MM. Lancet Neurol. 2023 Oct. PMID: 37739573.
- The search for treatments for inclusion body myositis.de Visser M, De Bleecker J. Lancet Neurol. 2023 Oct. PMID: 37739563.
- Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.Tavee J, Brannagan TH 3rd, Lenihan MW, Muppidi S, Kellermeyer L, D Donofrio P. Muscle Nerve. 2023 Oct; 2023 Jul 11. PMID: 37432872.
- Cytotoxic immune cells do not affect TDP-43 and p62 sarcoplasmic aggregation but influence TDP-43 localisation.McCord B, Day RM. Sci Rep. 2023 Sep 23; 2023 Sep 23. PMID: 37741931.
- Author Response: Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.Lloyd TE, Michelle EH, Pinal-Fernandez I, Mammen AL. Neurology. 2023 Sep 12. PMID: 37696675.
- Reader Response: Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis.Stenzel W, Goebel HH, Kleefeld F. Neurology. 2023 Sep 12. PMID: 37696674.